Compounds > n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide
Page last updated: 2024-09-05

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Leukemia, Myeloid, Acute

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Liu, M; Liu, X; Lu, Y; Luo, J; Nie, Z; Pan, Y; Wang, T; Wang, Z; Yang, L; Zhan, Y; Zhang, X1
Goralski, M; Hsiehchen, D; Kim, J; Nijhawan, D; Xie, Y1

Other Studies

2 other study(ies) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Leukemia, Myeloid, Acute

ArticleYear
Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
    Biochimica et biophysica acta. Molecular cell research, 2024, Volume: 1871, Issue:1

    Topics: Cell Line, Tumor; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt

2024
Biomarkers for RBM39 degradation in acute myeloid leukemia.
    Leukemia, 2020, Volume: 34, Issue:7

    Topics: Antineoplastic Agents; Biomarkers; Humans; Leukemia, Myeloid, Acute; Proteolysis; RNA-Binding Proteins; Sulfonamides; Tumor Cells, Cultured

2020